James Lorens
Stanford University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by James Lorens.
Immunity | 1998
Yasumichi Hitoshi; James Lorens; Shinichi Kitada; Joan M. Fisher; Mark A. LaBarge; Huijun Z. Ring; Uta Francke; John C. Reed; Shigemi Kinoshita; Garry P. Nolan
Fas is a surface receptor that can transmit signals for apoptosis. Using retroviral cDNA library-based functional cloning we identified a gene, toso, that blocks Fas-mediated apoptosis. Toso expression was confined to lymphoid cells and was enhanced after cell-specific activation processes in T cells. Toso appeared limited to inhibition of apoptosis mediated by members of the TNF receptor family and was capable of inhibiting T cell self-killing induced by TCR activation processes that up-regulate Fas ligand. We mapped the effect of Toso to inhibition of caspase-8 processing, the most upstream caspase activity in Fas-mediated signaling, potentially through activation of cFLIP. Toso therefore serves as a novel regulator of Fas-mediated apoptosis and may act as a regulator of cell fate in T cells and other hematopoietic lineages.
Immunity | 2002
Omar D. Perez; Shigemi Kinoshita; Yasumichi Hitoshi; Donald G. Payan; Toshio Kitamura; Garry P. Nolan; James Lorens
We identified intracellular adhesion molecule-2 (ICAM-2) in a genetic screen as an activator of the PI3K/AKT pathway leading to inhibition of apoptosis. ICAM-2 induced tyrosine phosphorylation of ezrin and PI3K kinase membrane translocation, resulting in phosphatidylinositol 3,4,5 production, PDK-1 and AKT activation, and subsequent phosphorylation of AKT targets BAD, GSK3, and FKHR. ICAM-2 clustering protected primary human CD19+ cells from TNFalpha- and Fas-mediated apoptosis as determined by single-cell analysis. ICAM-2 engagement by CD19+ cells of its natural receptor, LFA-1, on CD4+ naive cells specifically induced AKT activity in the absence of an MHC-peptide interaction. These results attribute a novel signaling function to ICAM-2 that might suggest mechanisms by which ICAM-2 signals intracellular communication at various immunological synapses.
Journal of Experimental Medicine | 1997
Michael K. Shaw; James Lorens; Archana Dhawan; Richard DalCanto; Harley Y. Tse; Alyssa B. Tran; Colleen Bonpane; Shanti L. Eswaran; Stefan Brocke; Nora Sarvetnick; Lawrence Steinman; Garry P. Nolan; C. Garrison Fathman
Molecular Therapy | 2000
James Lorens; M.K. Bennett; D.M. Pearsall; W.R. Throndset; A.B. Rossi; R.J. Armstrong; B.P. Fox; Eva Chan; Ying Luo; E. Masuda; D.A. Ferrick; D. C. Anderson; Donald G. Payan; Garry P. Nolan
Archive | 2005
James Lorens; Weiduan Xu; Jakob M. Bogenberger
Archive | 2003
James Lorens; Todd R. Pray; Todd M. Kinsella; Mark K. Bennett
Archive | 2003
James Lorens; Annabelle M. Friera; Sacha J. Holland
Archive | 1999
Joseph Fisher; James Lorens; Donald G. Payan; Alexander B. Rossi
Archive | 1999
Joseph Fisher; James Lorens; Donald G. Payan; Alexander B. Rossi
Archive | 2002
James Lorens; Todd M. Kinsella; Esteban Masuda; Yasumichi Hitoshi; X. Liao; Denise Pearsall; Annabelle M. Friera; Peter Chu